Hormone shot timing may affect recovery after prostate cancer treatment

NCT ID NCT00175383

First seen Jul 02, 2026 ยท Last updated Jul 02, 2026

Summary

This trial compares two types of hormone injections given before prostate brachytherapy (internal radiation) for early-stage prostate cancer. One injection lasts one month, the other three months, and both are used to lower testosterone to make radiation more effective. The study measures how quickly testosterone returns to normal after treatment, as well as PSA levels, quality of life, and sexual function. Participants are men with localized prostate cancer who are already recommended to receive hormone therapy as part of their brachytherapy plan.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
LHRH agonist (short-acting or long-acting injection)
What this could lead to
If one type allows faster testosterone recovery, it could help men regain normal hormone levels sooner after prostate cancer treatment.
What could go wrong
This is a small, single-center study comparing two drug schedules, not testing a new treatment. Results may not change standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BC Cancer Agency - Vancouver Island Centre

    Victoria, British Columbia, V8R 6V5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.